TransMedics Group Inc (TMDX) is a Healthcare · Medical Devices company listed on NASDAQ. Price $87.38 (+0.83%), Market cap $2.36B, P/E ratio 15.64, 52-week low–high $62.04 ~ $150.42.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanim
Financial statements, price targets, institutional (13F) holdings and related news for TransMedics Group Inc are updated in real time on BlackAll Trade.
TransMedics Group Inc trades at $87.38 (+0.83%). Real-time quotes and charts are available on BlackAll Trade.
TransMedics Group Inc has a market cap of about $2.36B. Its P/E ratio is 15.64.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.